Search Results

Displaying Results 176-200 of 851 "'JUN'"

Apr 01, 2026, 04:00 ET NSSK Closes Series IV Funds at JPY 250 Billion Hardcap, More Than 2x Oversubscribed

partners. We are grateful for the trust our investors have placed in us and look forward to putting this capital to work."— Jun Tsusaka, CEO and CIO, Nippon Sangyo Suishin Kiko (NSSK)"The oversubscription and speed of the NSSK Series IV Funds close

More news about: Thrive Alternatives; Nippon Sangyo Suishin Kiko (NSSK)


Mar 30, 2026, 21:00 ET RETOPIA SALON, Perusahaan yang Didirikan oleh Mantan Eksekutif HYBE, Gelar Audisi K-Pop di Jakarta dan Bandung pada 30 April untuk Mencari Member Debut 2027

kunci HYBE, termasuk CEO Bang Woo Jung (mantan Creative Studio Leader di HYBE Media Studio), CCO Kim Serene (mantan VP HYBE LABELS JAPAN), dan COO Park Jun Soo (mantan SP di HYBE Original Content Studio).Dengan pengalaman dan keahlian yang luas selama berkarier di HYBE, perusahaan ini berfokus pada

More news about: RETOPIA SALON


Mar 30, 2026, 11:00 ET Nexteer ने थाईलैंड में अपने मैन्यूफ़ैक्चरिंग प्लांट के भव्य उद्घाटन का समारोह मनाया और एशिया प्रशांत क्षेत्र में अपनी अनवरत वृद्धि को जारी रखा

क्षमताओं का विस्तार करने के लिए एक रणनीतिक निवेश का प्रतिनिधित्व करता है," Nexteer के वरिष्ठ उपाध्यक्ष, मुख्य रणनीति अधिकारी और APAC प्रभाग के अध्यक्ष, Jun Li ने कहा। "इस भव्य उद्घाटन के साथ, Nexteer अब अपने ग्राहकों की बढ़ती आवश्यकताओं को पूरा करने के लिए और भी बेहतर स्थिति में है। अपना उत्पादन बढ़ाने के

More news about: Nexteer Automotive


Mar 30, 2026, 06:45 ET Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System

and physiological changes in the urinary tract associated with ureteral dilation and ureteropyeloscopy: an experimental study. J Urol. 1993 Jun;149(6):1576–85.Zhong W, Leto G, Wang L, Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors.

More news about: Boston Scientific Corporation


Mar 30, 2026, 05:15 ET Nexteer Celebrates Grand Opening of Thailand Manufacturing Facility & Continued APAC Growth Momentum

responsiveness to our OEM customers, and our new Thailand facility represents a strategic investment to expand our capabilities in Southeast Asia," said Jun Li, Nexteer's Sr. Vice President, Chief Strategy Officer & APAC Division President. "With this grand opening, Nexteer is now even better positioned

More news about: Nexteer Automotive


Mar 24, 2026, 12:10 ET vivo at Boao Forum: Building a Perception System Driven by "Imaging + AI"

space.Showcasing the Leading Strengths of Chinese TechnologyOn the opening day of the BFA, Hu Baishan officially presented Zhang Jun, Secretary-General of the Boao Forum for Asia, with the vivo X300 Ultra as official smartphone for the forum.

More news about: vivo


Mar 23, 2026, 14:26 ET Galderma reúne profissionais injetores para apresentar as últimas tendências em estética injetável

18. Wu Y et al. J Cosmet Dermatol. 2020 Jul;19(7):1627-1635. 19. Philipp-Dormston WG, et al. Dermatol Surg. 2018 Jun;44(6):826-832 20. Rzany B, et al. Dermatol Surg. 2012 Jul;38(7 Pt 2):1153-61. 21. Segura S, et al. J Drugs Dermatol. 2012

More news about: Galderma


Mar 19, 2026, 05:16 ET What a flex: Swimming robot propelled by lab-grown muscle hits record speed

skeletal muscle. If the actuator is weak, the robot cannot move fast, generate meaningful thrust, or perform useful tasks," said Assistant Professor Tan Yu Jun from the Department of Mechanical Engineering in the

More news about: National University of Singapore (NUS)


Mar 18, 2026, 11:22 ET 總生存期顯著延長:蘆康沙妥珠單抗(sac-TMT) OptiTROP-Lung03研究OS最終分析結果亮相

tirumotecan versus docetaxel for previously treated EGFR-mutant advanced non-small-cell lung cancer: open label, randomised, multicentre trial[J]. BMJ. 2025 Jun 5:389:e085680. doi: 10.1136/bmj-2025-085680.[2] Fang W, Wu L, Meng X, et al. Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced

More news about: 科倫博泰


Mar 18, 2026, 10:27 ET Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study

tirumotecan versus docetaxel for previously treated EGFR-mutant advanced non-small-cell lung cancer: open label, randomised, multicentre trial[J]. BMJ. 2025 Jun 5:389:e085680. doi: 10.1136/bmj-2025-085680.[2]

More news about: Kelun-Biotech


Mar 18, 2026, 09:40 ET Sands China Presents "A Century of Iec Long Firecracker Factory in Radiance - An Exhibition on the Resonant History and Aesthetic Memory of Macao Firecrackers"

National People's Congress and vice principal of Hou Kong Middle School; Professor Zhang Zhiqing, dean of the Faculty of Humanities and Arts of MUST; Ni Jun Meng, senior search of MUST Library; Lok Hei, president of the Macau Artists Society; Professor Ung; Dr. Wong; Grant Chum, chief executive officer and

More news about: Sands China Ltd.


Mar 18, 2026, 08:00 ET Mammotome Secures FDA Clearance for Industry-First, In‑Room MR Vacuum‑Assisted Breast Biopsy System and New HydroMARK™ Plus MR Biopsy Site Markers

Gentile, Ann Surg Oncol. 2016 Oct;23(10):3284-9. doi: 10.1245/s10434-016-5325-x. Epub 2016 Jun 23.About MammotomeAt Mammotome, our expertise and compassion for breast care makes us the indispensable

More news about: MAMMOTOME


Mar 17, 2026, 19:00 ET Verismo Therapeutics to Present Novel Multi-chain KIR-CAR Data - Including Initial Clinical Trial Results for Lead Immuno-Oncology Candidates SynKIR™-110 and SynKIR™-310 - at AACR Annual Meeting 2026

KIR-CAR T overcomes CD3-based CAR T functional deficits to eliminate resistant glioblastomas in vivoPresenting Author: Jun Xu, Ph.D., Verismo TherapeuticsSession Title: Late-Breaking Research: Immunology 2Session Time: 4/20/2026 9:00

More news about: Verismo Therapeutics


Mar 17, 2026, 09:01 ET Co-PSMA data presented at EAU Annual Congress 2026 with manuscript accepted for publication in the European Urology journal

Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096. PMID: 30920593; PMCID: PMC6567829.Mena E, Lindenberg ML, Turkbey IB, Shih JH, Harmon SA, Lim

More news about: Clarity Pharmaceuticals


Mar 17, 2026, 08:59 ET Dahua Technology Pamerkan Solusi ITS yang Didukung AI di Ajang Intertraffic 2026

Dalam acara tersebut, Wang Jun, General Manager, ITS Product R&D, Dahua Technology, menyampaikan paparan berjudul "AI Empowering a Smarter, Safer, and Sustainable

More news about: Dahua Technology


Mar 17, 2026, 08:00 ET Dahua Technology predstavuje riešenia ITS s podporou AI na veľtrhu Intertraffic 2026

Na podujatí predniesol pán Wang Jun, generálny riaditeľ pre výskum a vývoj produktov ITS v Dahua Technology, hlavný prejav s názvom „AI podporuje inteligentnejšiu, bezpečnejšiu a udržateľnejšiu

More news about: Dahua Technology


Mar 17, 2026, 07:57 ET Dahua Technology демонстрирует решения для ИТС на базе искусственного интеллекта на выставке Intertraffic 2026

В ходе мероприятия г-н Ван Цзюнь (Wang Jun), генеральный менеджер по исследованиям и разработкам продукции в компании Dahua Technology, выступил с программным докладом под названием «ИИ для более

More news about: Dahua Technology


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.